Efficacy and safety of mirtazapine in university students with depression: A comparison with elderly patients

Terumi Ishii, Takafumi Hori, Hirokazu Tachikawa, Kimitaka Hatanaka, Takashi Asada

Research output: Contribution to journalArticle

Abstract

When clinicians are concerned about an increased risk of suicidality induced by antidepressants in young patients, mirtazapine is considered a suitable option because of its low risk of provoking suicidality and its sedative effect. However, mirtazapine often needs to be discontinued or the dose reduced because of drowsiness, especially in young persons. This study retrospectively compared the clinical effects of mirtazapine in 16 young university students to those in 16 elderly patients with depression. Drowsiness was the most frequent side effect, and was observed more often in the students. Greater numbers of students also had their doses reduced or stopped using mirtazapine specifically because of oversedation. Furthermore, the final dose of mirtazapine was much lower in the student group even though the therapeutic effects were similar to those in the elderly group, suggesting that lower doses of mirtazapine should be administered to young depressed patients as starting or maintenance doses to avoid sedation and achieve a minimal level of therapeutic efficacy.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalClinical Neuropsychopharmacology and Therapeutics
Volume6
Publication statusPublished - 2015 Jan 16
Externally publishedYes

Fingerprint

Depression
Students
Safety
Sleep Stages
Therapeutic Uses
Hypnotics and Sedatives
Antidepressive Agents
mirtazapine
Therapeutics

Keywords

  • Drowsiness
  • Histamine receptor
  • Mirtazapine
  • Suicidality
  • Young patients

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Efficacy and safety of mirtazapine in university students with depression : A comparison with elderly patients. / Ishii, Terumi; Hori, Takafumi; Tachikawa, Hirokazu; Hatanaka, Kimitaka; Asada, Takashi.

In: Clinical Neuropsychopharmacology and Therapeutics, Vol. 6, 16.01.2015, p. 1-4.

Research output: Contribution to journalArticle

@article{56a30467315f494985f283a159ccce6d,
title = "Efficacy and safety of mirtazapine in university students with depression: A comparison with elderly patients",
abstract = "When clinicians are concerned about an increased risk of suicidality induced by antidepressants in young patients, mirtazapine is considered a suitable option because of its low risk of provoking suicidality and its sedative effect. However, mirtazapine often needs to be discontinued or the dose reduced because of drowsiness, especially in young persons. This study retrospectively compared the clinical effects of mirtazapine in 16 young university students to those in 16 elderly patients with depression. Drowsiness was the most frequent side effect, and was observed more often in the students. Greater numbers of students also had their doses reduced or stopped using mirtazapine specifically because of oversedation. Furthermore, the final dose of mirtazapine was much lower in the student group even though the therapeutic effects were similar to those in the elderly group, suggesting that lower doses of mirtazapine should be administered to young depressed patients as starting or maintenance doses to avoid sedation and achieve a minimal level of therapeutic efficacy.",
keywords = "Drowsiness, Histamine receptor, Mirtazapine, Suicidality, Young patients",
author = "Terumi Ishii and Takafumi Hori and Hirokazu Tachikawa and Kimitaka Hatanaka and Takashi Asada",
year = "2015",
month = "1",
day = "16",
language = "English",
volume = "6",
pages = "1--4",
journal = "Clinical Neuropsychopharmacology and Therapeutics",
issn = "1884-8826",
publisher = "Japanese Society of Clinical Neuropsychopharmacology",

}

TY - JOUR

T1 - Efficacy and safety of mirtazapine in university students with depression

T2 - A comparison with elderly patients

AU - Ishii, Terumi

AU - Hori, Takafumi

AU - Tachikawa, Hirokazu

AU - Hatanaka, Kimitaka

AU - Asada, Takashi

PY - 2015/1/16

Y1 - 2015/1/16

N2 - When clinicians are concerned about an increased risk of suicidality induced by antidepressants in young patients, mirtazapine is considered a suitable option because of its low risk of provoking suicidality and its sedative effect. However, mirtazapine often needs to be discontinued or the dose reduced because of drowsiness, especially in young persons. This study retrospectively compared the clinical effects of mirtazapine in 16 young university students to those in 16 elderly patients with depression. Drowsiness was the most frequent side effect, and was observed more often in the students. Greater numbers of students also had their doses reduced or stopped using mirtazapine specifically because of oversedation. Furthermore, the final dose of mirtazapine was much lower in the student group even though the therapeutic effects were similar to those in the elderly group, suggesting that lower doses of mirtazapine should be administered to young depressed patients as starting or maintenance doses to avoid sedation and achieve a minimal level of therapeutic efficacy.

AB - When clinicians are concerned about an increased risk of suicidality induced by antidepressants in young patients, mirtazapine is considered a suitable option because of its low risk of provoking suicidality and its sedative effect. However, mirtazapine often needs to be discontinued or the dose reduced because of drowsiness, especially in young persons. This study retrospectively compared the clinical effects of mirtazapine in 16 young university students to those in 16 elderly patients with depression. Drowsiness was the most frequent side effect, and was observed more often in the students. Greater numbers of students also had their doses reduced or stopped using mirtazapine specifically because of oversedation. Furthermore, the final dose of mirtazapine was much lower in the student group even though the therapeutic effects were similar to those in the elderly group, suggesting that lower doses of mirtazapine should be administered to young depressed patients as starting or maintenance doses to avoid sedation and achieve a minimal level of therapeutic efficacy.

KW - Drowsiness

KW - Histamine receptor

KW - Mirtazapine

KW - Suicidality

KW - Young patients

UR - http://www.scopus.com/inward/record.url?scp=85043215175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043215175&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85043215175

VL - 6

SP - 1

EP - 4

JO - Clinical Neuropsychopharmacology and Therapeutics

JF - Clinical Neuropsychopharmacology and Therapeutics

SN - 1884-8826

ER -